Anna Jonsson

10.7k total citations · 1 hit paper
40 papers, 2.2k citations indexed

About

Anna Jonsson is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Anna Jonsson has authored 40 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 17 papers in Endocrinology, Diabetes and Metabolism and 16 papers in Molecular Biology. Recurrent topics in Anna Jonsson's work include Genetic Associations and Epidemiology (13 papers), Diet and metabolism studies (9 papers) and Diabetes Treatment and Management (8 papers). Anna Jonsson is often cited by papers focused on Genetic Associations and Epidemiology (13 papers), Diet and metabolism studies (9 papers) and Diabetes Treatment and Management (8 papers). Anna Jonsson collaborates with scholars based in Denmark, Sweden and Finland. Anna Jonsson's co-authors include Leif Groop, Valeriya Lyssenko, Bo Isomaa, Peter M. Nilsson, Torben Hansen, Nicolò Pulizzi, David Altshuler, Peter Almgren, Oluf Pedersen and Göran Berglund and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Anna Jonsson

40 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Risk Factors, DNA Variants, and the Development of Type 2 Diabetes

2008 649 citations Valeriya Lyssenko, Anna Jonsson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Jonsson Denmark	20	871	793	791	547	471	40	2.2k
Mikko Lehtovirta Finland	24	966 1.1×	654 0.8×	690 0.9×	456 0.8×	530 1.1×	42	2.3k
Bo Isomaa Finland	21	1.1k 1.3×	1.2k 1.5×	850 1.1×	787 1.4×	381 0.8×	36	2.6k
Stéphane Cauchi France	26	602 0.7×	1.2k 1.5×	973 1.2×	516 0.9×	357 0.8×	42	2.4k
James L. Rosenzweig United States	22	1.9k 2.1×	630 0.8×	708 0.9×	717 1.3×	341 0.7×	34	2.8k
Jørn V. Sagen Norway	25	664 0.8×	787 1.0×	809 1.0×	1000 1.8×	350 0.7×	66	2.2k
Kun‐san Xiang China	28	986 1.1×	706 0.9×	1.5k 1.9×	738 1.3×	472 1.0×	118	3.2k
Emil Chuang United States	24	452 0.5×	525 0.7×	478 0.6×	624 1.1×	419 0.9×	56	2.4k
Carola Saloranta Finland	27	1.4k 1.6×	828 1.0×	982 1.2×	849 1.6×	788 1.7×	39	3.0k
Nuala Murphy Ireland	30	1.1k 1.2×	547 0.7×	457 0.6×	514 0.9×	234 0.5×	81	2.5k
Kurt Kristensen Denmark	25	816 0.9×	608 0.8×	552 0.7×	241 0.4×	738 1.6×	80	2.3k

Countries citing papers authored by Anna Jonsson

Since Specialization

Citations

This map shows the geographic impact of Anna Jonsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Jonsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Jonsson more than expected).

Fields of papers citing papers by Anna Jonsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Jonsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Jonsson. The network helps show where Anna Jonsson may publish in the future.

Co-authorship network of co-authors of Anna Jonsson

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Jonsson. A scholar is included among the top collaborators of Anna Jonsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Jonsson. Anna Jonsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stinson, Sara, Anna Jonsson, Mette K. Andersen, et al.. (2023). High Plasma Levels of Soluble Lectin‐like Oxidized Low‐Density Lipoprotein Receptor‐1 Are Associated With Inflammation and Cardiometabolic Risk Profiles in Pediatric Overweight and Obesity. Journal of the American Heart Association. 12(3). e8145–e8145. 9 indexed citations

Andersen, Mette K., Lars Ängquist, Jette Bork‐Jensen, et al.. (2023). Physical Activity and Insulin Sensitivity Independently Attenuate the Effect of FTO rs9939609 on Obesity. Diabetes Care. 46(5). 985–992. 6 indexed citations

Stinson, Sara, Morten Asp Vonsild Lund, Cilius Esmann Fonvig, et al.. (2023). Altered Glucagon and GLP-1 Responses to Oral Glucose in Children and Adolescents With Obesity and Insulin Resistance. The Journal of Clinical Endocrinology & Metabolism. 109(6). 1590–1600. 7 indexed citations

Durda, Peter, Laura M. Raffield, Ethan M. Lange, et al.. (2022). Circulating Soluble CD163, Associations With Cardiovascular Outcomes and Mortality, and Identification of Genetic Variants in Older Individuals: The Cardiovascular Health Study. Journal of the American Heart Association. 11(21). e024374–e024374. 19 indexed citations

Stinson, Sara, Anna Jonsson, Morten Asp Vonsild Lund, et al.. (2021). Fasting Plasma GLP-1 Is Associated With Overweight/Obesity and Cardiometabolic Risk Factors in Children and Adolescents. The Journal of Clinical Endocrinology & Metabolism. 106(6). 1718–1727. 42 indexed citations

Lundgren, J., Kristine Færch, Daniel R. Witte, et al.. (2019). Greater glucagon-like peptide-1 responses to oral glucose are associated with lower central and peripheral blood pressures. Cardiovascular Diabetology. 18(1). 130–130. 8 indexed citations

Albrechtsen, Nicolai J. Wewer, Kristine Færch, Troels Mygind Jensen, et al.. (2018). Evidence of a liver–alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids. Diabetologia. 61(3). 671–680. 87 indexed citations

Engelbrechtsen, Line, Yuvaraj Mahendran, Anna Jonsson, et al.. (2018). Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses. BMC Genetics. 19(1). 15–15. 13 indexed citations

Engelbrechtsen, Line, Yuvaraj Mahendran, Paul Theodor Pyl, et al.. (2017). Homozygous carriers of the TCF7L2 rs7903146 T-allele show altered postprandial response in triglycerides and triglyceride-rich lipoproteins. Scientific Reports. 7(1). 43128–43128. 12 indexed citations

10.

Mahendran, Yuvaraj, Anna Jonsson, Kristine H. Allin, et al.. (2017). Genetic evidence of a causal effect of insulin resistance on branched-chain amino acid levels. Diabetologia. 60(5). 873–878. 115 indexed citations

11.

Hulmán, Ádám, Rebecca K. Simmons, Dorte Vistisen, et al.. (2016). Heterogeneity in glucose response curves during an oral glucose tolerance test and associated cardiometabolic risk. Endocrine. 55(2). 427–434. 22 indexed citations

12.

Færch, Kristine, Signe S. Torekov, Dorte Vistisen, et al.. (2015). GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study. Diabetes. 64(7). 2513–2525. 252 indexed citations

13.

Jonsson, Anna, et al.. (2012). Effect of a common variant of the PCSK2 gene on reduced insulin secretion. Diabetologia. 55(12). 3245–3251. 14 indexed citations

14.

Vassy, Jason L., Peter Shrader, Anna Jonsson, et al.. (2011). Association between parental history of diabetes and type 2 diabetes genetic risk scores in the PPP-Botnia and Framingham Offspring Studies. Diabetes Research and Clinical Practice. 93(2). e76–e79. 20 indexed citations

15.

Guey, Lin T., Jasmina Kravić, Olle Melander, et al.. (2011). Power in the phenotypic extremes: a simulation study of power in discovery and replication of rare variants. Genetic Epidemiology. 35(4). 236–246. 78 indexed citations

16.

Hertel, Jens Kristoffer, Stefan Johansson, Emily Sonestedt, et al.. (2011). FTO, Type 2 Diabetes, and Weight Gain Throughout Adult Life. Diabetes. 60(5). 1637–1644. 101 indexed citations

17.

Pulizzi, Nicolò, Valeriya Lyssenko, Anna Jonsson, et al.. (2009). Interaction between prenatal growth and high-risk genotypes in the development of type 2 diabetes. Diabetologia. 52(5). 825–829. 42 indexed citations

18.

Osmark, Peter, Ola Hansson, Anna Jonsson, et al.. (2009). Unique splicing pattern of the TCF7L2 gene in human pancreatic islets. Diabetologia. 52(5). 850–854. 58 indexed citations

19.

Jonsson, Anna, et al.. (2008). Metabolic effects of novel type 2 diabetes genes in a population aged 18-75 years. Lund University Publications (Lund University). 1 indexed citations

20.

Sjögren, Magnus, Anna Jonsson, G. Berglund, et al.. (2008). The search for putative unifying genetic factors for components of the metabolic syndrome. Diabetologia. 51(12). 2242–2251. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact